Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsQuantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic reviewExtensive genome rearrangements and multiple horizontal gene transfers in a population of pyrococcus isolates from Vulcano Island, ItalyTranscriptomic response of Listeria monocytogenes to iron limitation and Fur mutation.Functional characterization of TcaA: minimal requirement for teicoplanin susceptibility and role in Caenorhabditis elegans virulenceCharacterization of nontypable Haemophilus influenzae isolates recovered from adult patients with underlying chronic lung disease reveals genotypic and phenotypic traits associated with persistent infection.DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus.Diversity and strain specificity of plant cell wall degrading enzymes revealed by the draft genome of Ruminococcus flavefaciens FD-1The epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada.Using chemical derivatization and mass spectrometric analysis to characterize the post-translationally modified Staphylococcus aureus surface protein GtcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.Vancomycin stress response in a sensitive and a tolerant strain of Streptococcus pneumoniae.Physiological significance of the peptidoglycan hydrolase, LytM, in Staphylococcus aureusPassive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters.The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibilityIn vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.Staphylococcus aureus mutants with increased lysostaphin resistance.Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approachWhole-genome expression profiling of Thermotoga maritima in response to growth on sugars in a chemostatResponse of Staphylococcus aureus to salicylate challenge.Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysisGenetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.Responses of wild-type and resistant strains of the hyperthermophilic bacterium Thermotoga maritima to chloramphenicol challenge.Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis.Genetic Screen Reveals the Role of Purine Metabolism in Staphylococcus aureus Persistence to Rifampicin.Genome-wide transcriptional changes in Streptococcus gordonii in response to competence signaling peptideSpontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus.Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Genomic, Transcriptomic and Metabolomic Studies of Two Well-Characterized, Laboratory-Derived Vancomycin-Intermediate Staphylococcus aureus Strains Derived from the Same Parent Strain.Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains.Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureussarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.Extensive and genome-wide changes in the transcription profile of Staphylococcus aureus induced by modulating the transcription of the cell wall synthesis gene murF.Complete Genome Sequence of Vancomycin-Intermediate Staphylococcus aureus Strain MI (HIP5827).Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
P2860
Q24646677-054105DA-9769-491B-B682-93DCA08307D8Q26796165-AADC4850-1ABE-49F8-939F-87476BE01754Q28756794-BF7141A5-93AC-4A41-A9AA-2AB7B6E561BDQ29346599-B6EB69D7-BB13-44DD-8131-A1960C76ABCCQ30443507-CEBEF613-8961-41E6-B47A-B914A9A50643Q31161151-E1E69CF7-1F7D-4A36-A796-E2AE5E46C3C1Q33220466-EA473270-8B92-4798-AFE8-E0D3488D70D4Q33264418-A563A4D1-DF5F-49CB-A541-2F667C06C876Q33296902-1590C12F-6E33-48F8-B68C-EC571D14CD01Q33493425-F7112830-3F58-4B72-B47E-946E3010B0F5Q33728644-255E722B-750B-49F9-AA0A-144B863638ABQ33771587-641F4635-02A7-4484-ADC5-350E286784E7Q34141289-A495506F-6441-4F49-A389-43F209985685Q34151003-B244E942-2CEA-4207-9A74-76B40A4DFF6EQ34152544-823DDB59-FAF5-4817-BD72-84B5B6CAF67AQ34522708-698A9F7C-747E-4148-8402-B868D910B6DBQ34596835-64ED42A0-8012-4C63-8B2F-045CCC2C921FQ34632683-921E4BAE-C68E-4BBA-9F9B-3FD90091324DQ34721614-77C4DD65-DD49-436C-B65F-E251147582B0Q35023285-5D4EF304-7A17-4CDE-932C-20ABD1FA6513Q35023343-8B68CBF6-5F7F-4159-BF3E-DCE0C3B816B8Q35075303-198BF899-11B7-4216-99D4-92BE75BF2E22Q35096905-E48247BB-8453-41A6-8FFF-0466C0FB98C2Q35279541-BDB2AD42-F382-4360-9519-5F6938D8C13CQ35634244-54470C6D-2D7D-4801-9DF4-4200B1869923Q35635966-1423DCAE-BF83-43ED-ACB4-DE3F6A3EB8D9Q35728976-7B4EBDB8-28FB-4ECB-B704-AB8B080052F8Q35946804-A8F99158-BFCF-4408-A40C-D2C82063B612Q35947342-5ECB0068-8CA3-4BE5-A9CC-12818497E112Q35973186-5AA4A13C-4EB2-42F6-9EBA-FE41461D4304Q36314865-4723B18A-7C26-4344-80F7-38E49D57E752Q36538634-09667C5C-E769-4C23-9943-56AA3CC0C348Q36670735-85D8CC72-2E07-4CD0-B34B-7E1BB0B178C0Q36683542-810701E3-920E-4C6D-BD92-A9E14AE4AC12Q36964857-9AEC287F-18A0-4AA6-AF54-06BF4281B40CQ37115797-175D7867-C1F0-4BF3-B254-6A12791F2278Q37318624-D8A4CCE6-186B-46B3-8820-8BAFF117EA23Q38306144-61AFE396-3151-4C03-A067-6F72AFD9AB3DQ39107971-D9B2DC30-6341-4A52-8D7B-8DE60612938CQ40166227-81D7E31A-CEDD-4A73-BBAC-C6C95EA8AB54
P2860
Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Microarray transcription analy ...... olates resistant to vancomycin
@en
Microarray transcription analy ...... lates resistant to vancomycin.
@nl
type
label
Microarray transcription analy ...... olates resistant to vancomycin
@en
Microarray transcription analy ...... lates resistant to vancomycin.
@nl
prefLabel
Microarray transcription analy ...... olates resistant to vancomycin
@en
Microarray transcription analy ...... lates resistant to vancomycin.
@nl
P2093
P2860
P1476
Microarray transcription analy ...... olates resistant to vancomycin
@en
P2093
Emmanuel Mongodin
Gordon L Archer
Michael W Climo
Steven Gill
P2860
P304
P356
10.1128/JB.185.15.4638-4643.2003
P407
P577
2003-08-01T00:00:00Z